From: Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013
Characteristic | All cases | Sinonasal tract | Oral cavity & oropharynx | p-value |
---|---|---|---|---|
N = 61 (%) | N = 44 (%) | N = 16 (%) | ||
Age at diagnosis (years) | ||||
Median | 75.5 | 77.0 | 68.2 | 0.059 |
Range | 25.9–91.8 | 40.0–91.8 | 25.9–87.3 | |
Sex | ||||
Male | 32 (53) | 20 (46) | 11 (69) | 0.110 |
Female | 29 (48) | 24 (55) | 5 (31) | |
PS WHO | ||||
Grade 0 | 29 (48) | 18 (41) | 10 (63) | 0.276 |
Grade 1 | 23 (38) | 18 (41) | 5 (31) | |
Grade >1 | 9 (15) | 8 (18) | 1 (6.3) | |
Duration of symptoms (months) | ||||
Median | 2.0 | 2.0 | 1.0 | 0.554 |
Range | 0.0–12.0 | 0.0–12.0 | 0.0–12.0 | |
Tumor pigmentation | ||||
Yes | 36 (59) | 23 (52) | 13 (81) | 0.165 |
No | 13 (21) | 11 (25) | 2 (13) | |
Unknown | 12 (20) | 10 (237) | 1 (6.3) | |
Overall stage | ||||
1 | 48 (79) | 38 (86) | 9 (56) | 0.029 |
2 | 10 (16) | 4 (9.1) | 6 (38) | |
3 | 3 (4.9) | 2 (4.5) | 1 (6.3) | |
TNM stage | ||||
III | 21 (34) | 16 (36) | 4 (25) | 0.203 |
IVA | 30 (49) | 19 (43) | 11 (69) | |
IVB | 7 (12) | 7 (16) | 0 (0.0) | |
IVC | 3 (4.9) | 2 (4.5) | 1 (6.3) | |
Treatment intent | ||||
Curative | 48 (79) | 33 (75) | 14 (88) | 0.299 |
Palliative | 13 (21) | 11 (25) | 2 (13) | |
Surgery | ||||
No | 22 (36) | 20 (46) | 2 (13) | 0.019 |
Yes | 39 (64) | 24 (55) | 14 (88) | |
Open surgery | 24 (62) | 10 (42) | 13 (93) | 0.002 |
Endoscopic surgery | 15 (39) | 14 (58) | 1 (7.1) | |
Radiotherapy | ||||
No | 28 (46) | 21 (48) | 7 (44) | 0.785 |
Yes | 33 (54) | 23 (52) | 9 (56) | |
Definitive | 11 (33) | 9 (39) | 2 (22) | 0.066 |
Postoperative | 16 (49) | 8 (35) | 7 (78) | |
Palliative | 6 (18) | 6 (26) | 0 (0.0) | |
Systemic therapy | ||||
Yes | 13 (21) | 10 (23) | 3 (19) | 0.741 |
No | 48 (79) | 34 (77) | 13 (81) | |
2-year overall survivala | 43 (30–55) | 40 (26–55) | 54 (29–79) | 0.548 |
5-year overall survivala | 18 (7.8–29) | 20 (7.4–32) | 15 (0.0–35) | 0.548 |